Yang Liu

Chief Executive Officer at OncoImmune, Inc.

Commercial Services

Health Technology

Profile

Yang Liu is the founder of OncoImmune, Inc., which was founded in 2000.
He holds the titles of Chairman, CEO & Chief Scientific Officer.
Currently, Dr. Liu is the Director at Global Virus Network.

Yang Liu active positions

Companies	Position	Start
OncoImmune, Inc. OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD.	Chief Executive Officer	1999-12-31
Global Virus Network Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo.	Director/Board Member	-

All active positions of Yang Liu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yang Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Global Virus Network Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo.	Commercial Services
OncoImmune, Inc. OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD.	Health Technology